# Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer

> **NCT04341883** · PHASE2 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 27 (actual)

## Conditions studied

- Recurrent Cervical Cancer

## Interventions

- **DRUG:** anti-PD-1+Albumin-Bound Paclitaxel

## Key facts

- **NCT ID:** NCT04341883
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-13
- **Primary completion:** 2022-05-22
- **Final completion:** 2024-04-26
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2026-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04341883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04341883, "Study of Anti-PD-1 Combined With Albumin-Bound Paclitaxel in Patients With Recurrent Cervical Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04341883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*